NXTC Q1 2021 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena

NXTCNextCure, Inc.

$35M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$17M

Net Income

-$17M

EPS (Diluted)

$-7.19

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$291M

Total Liabilities

$12M

Stockholders' Equity

$279M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$22M	-100.0%
Gross Profit	$0	$12M	-100.0%
Operating Income	-$17M	$8M	-309.9%
Net Income	-$17M	$10M	-269.9%